Description
Ultima-Ipamorelin, 5 mg
Ultima-Ipamorelin 5 mg contains ipamorelin, a selective growth hormone secretagogue that stimulates the release of growth hormone (GH). It is particularly associated with recovery, lean-muscle development, body composition, sleep support, and growth-hormone signaling, making it a popular peptide for fitness and performance-focused applications.
How it works
Ipamorelin works primarily through the growth hormone secretagogue receptor (GHS-R), stimulating the pituitary gland to release growth hormone.
Its selective activity makes ipamorelin particularly interesting for protocols focused on GH release and recovery. Increased GH activity can influence the GH–IGF-1 axis, supporting processes related to protein synthesis, tissue recovery, fat metabolism, and body composition.
Proper Use and Dosage
The listed presentation contains 5 mg (5,000 mcg) of ipamorelin.
Commonly referenced peptide protocols use approximately 100–300 mcg per administration, depending on the intended application.
For a 5 mg presentation:
50 mcg = 100 administrations
100 mcg = 50 administrations
150 mcg = approximately 33 administrations
200 mcg = 25 administrations
250 mcg = 20 administrations
300 mcg = approximately 16–17 administrations
500 mcg = 10 administrations
1 mg = 5 administrations
2.5 mg = 2 administrations
5 mg = 1 full vial
For fitness-focused applications, ipamorelin is commonly incorporated into protocols centered around growth-hormone support, recovery, sleep, lean-mass development, and body composition.
Benefits
Ultima-Ipamorelin is particularly suited to applications involving growth-hormone stimulation, recovery, muscle development, sleep, and physique enhancement.
Key benefits and areas of interest include:
Stimulates endogenous growth hormone release
Supports GH–IGF-1 pathway activity
Supports lean-muscle development
Promotes recovery after demanding training
Supports tissue-repair pathways
May complement fat-loss and body-composition goals
Supports sleep-related growth-hormone activity
Provides selective growth-hormone secretagogue activity
Suitable for recovery-focused peptide protocols
Convenient 5 mg presentation
Its selective GH-secretagogue profile makes ipamorelin particularly attractive for individuals looking for growth-hormone support and recovery-focused benefits.
Side Effects
Possible effects may include injection-site irritation, headache, dizziness, nausea, fatigue, increased appetite, water retention, and temporary changes in blood glucose. Increased GH activity may also contribute to joint discomfort, swelling, or tingling sensations in some individuals.
